Connect Biopharma (CNTB) News Today $1.04 -0.01 (-0.77%) As of 01/17/2025 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Connect Biopharma (NASDAQ:CNTB) Stock Price Down 0.8% - Here's What HappenedJanuary 21 at 1:45 AM | americanbankingnews.comConnect Biopharma (NASDAQ:CNTB) Shares Down 0.8% - Should You Sell?Connect Biopharma (NASDAQ:CNTB) Shares Down 0.8% - Time to Sell?January 21 at 1:43 AM | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 53.5% in DecemberConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 87,800 shares, a growth of 53.5% from the November 30th total of 57,200 shares. Based on an average daily trading volume, of 28,200 shares, the days-to-cover ratio is presently 3.1 days. Approximately 0.2% of the shares of the stock are sold short.December 28, 2024 | marketbeat.comConnect Biopharma Appoints New Accounting FirmDecember 23, 2024 | tipranks.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 7.4% in NovemberConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 30th, there was short interest totalling 57,200 shares, a decrease of 7.4% from the November 15th total of 61,800 shares. Based on an average daily trading volume, of 26,600 shares, the days-to-cover ratio is presently 2.2 days. Currently, 0.1% of the company's stock are short sold.December 16, 2024 | marketbeat.comConnect Biopharma Hldgs (NASDAQ:CNTB) Stock, Option ChainNovember 14, 2024 | benzinga.comShort Interest in Connect Biopharma Holdings Limited (NASDAQ:CNTB) Increases By 26.7%Connect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 45,500 shares, an increase of 26.7% from the September 30th total of 35,900 shares. Based on an average daily volume of 27,300 shares, the short-interest ratio is presently 1.7 days. Currently, 0.1% of the shares of the company are sold short.October 30, 2024 | marketbeat.comAttovia Therapeutics Appoints Chief Financial OfficerOctober 15, 2024 | globenewswire.comCNTB Stock Surges Over 5% Amid Strong Financial PerformanceOctober 2, 2024 | gurufocus.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Sees Large Growth in Short InterestConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large increase in short interest in September. As of September 15th, there was short interest totalling 22,400 shares, an increase of 5.2% from the August 31st total of 21,300 shares. Approximately 0.0% of the company's stock are sold short. Based on an average trading volume of 42,600 shares, the short-interest ratio is currently 0.5 days.October 1, 2024 | marketbeat.comCentessa Pharmaceuticals: Progressing SerpinPC Through Registrational Trials In Hemophilia BSeptember 25, 2024 | seekingalpha.comSimcere Pharmaceutical Group Ltd (S2P.DU)September 25, 2024 | sg.finance.yahoo.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 76.0% in AugustConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large increase in short interest during the month of August. As of August 31st, there was short interest totalling 21,300 shares, an increase of 76.0% from the August 15th total of 12,100 shares. Based on an average trading volume of 50,600 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.0% of the company's shares are sold short.September 13, 2024 | marketbeat.comConnect Biopharma to Participate in the Cantor Fitzgerald Global Healthcare Conference 2024September 10, 2024 | finance.yahoo.comHC Wainwright Reaffirms "Buy" Rating for Connect Biopharma (NASDAQ:CNTB)HC Wainwright restated a "buy" rating and issued a $8.00 target price on shares of Connect Biopharma in a research note on Friday.September 6, 2024 | marketbeat.comConnect Biopharma Reports First Half 2024 Financial Results and Provides Business UpdateSeptember 5, 2024 | globenewswire.comShort Interest in Connect Biopharma Holdings Limited (NASDAQ:CNTB) Decreases By 9.7%Connect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 12,100 shares, a decrease of 9.7% from the July 31st total of 13,400 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily trading volume, of 48,900 shares, the short-interest ratio is presently 0.2 days.September 1, 2024 | marketbeat.comConnect Biopharma Holdings (NASDAQ:CNTB) Is In A Good Position To Deliver On Growth PlansAugust 29, 2024 | finance.yahoo.comConnect Biopharma Holdings Limited Share ChatAugust 25, 2024 | lse.co.ukConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 44.2% in JuneConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large drop in short interest in the month of June. As of June 30th, there was short interest totalling 15,500 shares, a drop of 44.2% from the June 15th total of 27,800 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 83,900 shares, the short-interest ratio is currently 0.2 days.July 12, 2024 | marketbeat.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest UpdateConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 27,800 shares, a decrease of 21.5% from the May 31st total of 35,400 shares. Based on an average daily volume of 114,100 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.1% of the company's stock are short sold.July 1, 2024 | marketbeat.comConnect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics ForumJuly 1, 2024 | globenewswire.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 34.6% in MayConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 35,400 shares, a drop of 34.6% from the May 15th total of 54,100 shares. Approximately 0.1% of the company's shares are sold short. Based on an average daily volume of 118,800 shares, the days-to-cover ratio is presently 0.3 days.June 16, 2024 | marketbeat.comConnect Biopharma Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)June 12, 2024 | globenewswire.comConnect Biopharma Announces New Leadership and Chair of the Board of DirectorsJune 12, 2024 | globenewswire.comConnect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe AsthmaMay 22, 2024 | globenewswire.comConnect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe AsthmaMay 7, 2024 | globenewswire.comConnect Biopharma Holdings Limited (CNTB)April 26, 2024 | finance.yahoo.comBML Capital Management LLC Makes New $2.43 Million Investment in Connect Biopharma Holdings Limited (NASDAQ:CNTB)BML Capital Management LLC acquired a new position in Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,061,438 shares of the company's stoApril 24, 2024 | marketbeat.comHC Wainwright Analysts Lift Earnings Estimates for Connect Biopharma Holdings Limited (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Equities researchers at HC Wainwright boosted their FY2024 earnings estimates for shares of Connect Biopharma in a note issued to investors on Wednesday, April 17th. HC Wainwright analyst E. Bodnar now anticipates that the company wApril 19, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Given New $8.00 Price Target at HC WainwrightHC Wainwright raised their price target on Connect Biopharma from $7.00 to $8.00 and gave the company a "buy" rating in a research report on Wednesday.April 17, 2024 | marketbeat.comAnalysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Connect Biopharma Holdings (CNTB)April 17, 2024 | markets.businessinsider.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Up 7.5% in MarchConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 115,500 shares, a growth of 7.5% from the March 15th total of 107,400 shares. Approximately 0.2% of the company's shares are short sold. Based on an average daily volume of 158,600 shares, the short-interest ratio is presently 0.7 days.April 17, 2024 | marketbeat.comConnect Biopharma Reports Full Year 2023 Financial Results and Provides Business UpdateApril 16, 2024 | globenewswire.comFY2025 EPS Estimates for Connect Biopharma Holdings Limited (NASDAQ:CNTB) Lifted by Leerink PartnrsConnect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Analysts at Leerink Partnrs boosted their FY2025 earnings per share estimates for Connect Biopharma in a research note issued to investors on Tuesday, April 9th. Leerink Partnrs analyst T. Smith now forecasts that the company will pApril 12, 2024 | marketbeat.comBuy Rating Reaffirmed for Connect Biopharma Holdings Amid Promising Clinical Trials and Strategic PartnershipsApril 11, 2024 | markets.businessinsider.comADRs Advance; Connect Biopharma Climbs 19%April 7, 2024 | marketwatch.comADRs End Higher; Connect Biopharma Climbs 26%April 1, 2024 | marketwatch.comConnect Biopharma Holdings Limited (NASDAQ:CNTB) Short Interest Down 13.2% in MarchConnect Biopharma Holdings Limited (NASDAQ:CNTB - Get Free Report) was the recipient of a significant decline in short interest in March. As of March 15th, there was short interest totalling 107,400 shares, a decline of 13.2% from the February 29th total of 123,700 shares. Approximately 0.2% of the company's stock are sold short. Based on an average daily trading volume, of 133,300 shares, the days-to-cover ratio is currently 0.8 days.March 30, 2024 | marketbeat.comConnect Biopharma to Participate in H.C. Wainwright 2n? Annual Autoimmune & Inflammatory Disease Virtual ConferenceMarch 19, 2024 | tmcnet.comConnect Biopharma to Participate in H.C. Wainwright 2ⁿᵈ Annual Autoimmune & Inflammatory Disease Virtual ConferenceMarch 19, 2024 | globenewswire.comEquities Analysts Issue Forecasts for Connect Biopharma Holdings Limited's FY2023 Earnings (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - HC Wainwright issued their FY2023 earnings estimates for shares of Connect Biopharma in a note issued to investors on Monday, March 4th. HC Wainwright analyst E. Bodnar forecasts that the company will earn ($0.70) per share for theMarch 6, 2024 | marketbeat.comHC Wainwright & Co. Initiates Coverage of Connect Biopharma Holdings Limited - Depositary Receipt () (CNTB) with Buy RecommendationMarch 5, 2024 | msn.comConnect Biopharma (NASDAQ:CNTB) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright began coverage on shares of Connect Biopharma in a report on Monday. They set a "buy" rating and a $7.00 price target for the company.March 4, 2024 | marketbeat.comConnect Biopharma Hldgs Stock (NASDAQ:CNTB) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comConnect Biopharma Appoints Industry Veteran James Huang to Board of DirectorsFebruary 12, 2024 | finance.yahoo.comFY2024 EPS Estimates for Connect Biopharma Holdings Limited Lowered by Analyst (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2024 earnings per share estimates for Connect Biopharma in a report issued on Monday, February 5th. Leerink Partnrs analyst T. Smith now anticipates that the company will post eFebruary 8, 2024 | marketbeat.comLeerink Partnrs Comments on Connect Biopharma Holdings Limited's FY2028 Earnings (NASDAQ:CNTB)Connect Biopharma Holdings Limited (NASDAQ:CNTB - Free Report) - Stock analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for Connect Biopharma in a report released on Monday, February 5th. Leerink Partnrs analyst T. Smith forecasts that the company will earn ($0.44) perFebruary 7, 2024 | marketbeat.comConnect Biopharma (NASDAQ:CNTB) Trading 4% Higher Connect Biopharma (NASDAQ:CNTB) Shares Up 4%February 3, 2024 | marketbeat.comWill Connect Biopharma Holdings (NASDAQ:CNTB) Spend Its Cash Wisely?January 29, 2024 | finance.yahoo.com Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address CNTB Media Mentions By Week CNTB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTB News Sentiment▼1.000.46▲Average Medical News Sentiment CNTB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTB Articles This Week▼00▲CNTB Articles Average Week Get Connect Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies URGN News Today ATAI News Today LFCR News Today HRTX News Today DSGN News Today ELDN News Today CMPS News Today FULC News Today SOPH News Today LRMR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTB) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Connect Biopharma Holdings Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Connect Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
